文章核心观点 - 公司因未支付纳斯达克上市规则5900系列规定的费用而收到退市通知，但在支付所有未付费用后，问题已解决，公司股票交易未受影响 [1][2][3][4] 公司行动 - 公司在2024年11月26日全额支付了未付费用 [2] - 公司在2024年11月27日收到纳斯达克的通知，确认费用问题已解决 [2] - 公司目前符合纳斯达克上市规则5250(f)的要求 [3] 市场影响 - 公司股票交易未受影响，继续正常交易 [4] - 退市通知不影响公司的业务运营或财务状况，公司仍专注于业务增长 [4] 公司概况 - 公司是一家提供运输服务的公司，采用环保实践，旨在促进建筑和拆除材料的再利用和减少建筑垃圾 [5] - 公司通过在香港的运营子公司，主要从事建筑行业，处理从建筑工地挖掘的材料的运输 [5] - 公司主要提供的服务包括土壤和岩石运输服务、柴油油品交易以及建筑工程，主要涉及挖掘和侧向支撑工程及钻孔桩工程 [5] - 公司通常作为香港其他建筑承包商的子承包商提供服务 [5] 前瞻性声明 - 新闻稿中的某些声明是前瞻性声明，涉及已知和未知的风险和不确定性，基于公司对未来事件的当前预期和预测 [6] - 公司不承担更新或公开修订前瞻性声明的义务，除非法律要求 [6] 联系信息 - 公司信息：Primega Group Holdings Limited，联系人：Man Siu Ming，Director and Chairman of the Board，邮箱：msm@primegagroup.com，电话：+852 3997 3682 [7] - 投资者关系：HBK Strategy Limited，联系人：Katy Chan，Director，邮箱：ir@hbkstrategy.com，电话：+852 2498 3681 [7][8]

BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced the grant of an inducement option award to its newly appointed interim chief development officer, Daniel Baker, M.D. The grant was approved by a majority of the independent directors of the Company as induce ...

公司核心观点 - 公司宣布已收到纳斯达克通知，恢复符合纳斯达克上市规则5550(a)(2)的最低出价要求 [1][3] 公司恢复合规的背景 - 公司曾于2024年8月7日收到纳斯达克通知，指出其美国存托股票（ADS）在过去30个连续交易日内的收盘价低于纳斯达克上市规则5550(a)(2)规定的每股1美元的最低出价要求 [3] - 根据纳斯达克上市规则5810(c)(3)(A)，公司被给予180天的合规期，即至2025年2月3日，以恢复合规 [3] - 如果在180天合规期内，公司ADS的收盘价连续10个交易日达到或超过每股1美元，纳斯达克将确认公司合规 [3] - 根据通知，公司ADS在2024年11月13日至11月26日的10个连续交易日内的收盘价均达到或超过每股1美元，因此公司已恢复符合最低出价要求 [3] 公司CEO的评论 - CEO表示公司非常重视纳斯达克上市，并很高兴恢复合规 [2] 公司简介 - 公司成立于2011年，总部位于北京，是中国领先的数字教育内容提供商 [4] - 公司致力于开发教育内容，满足中国市场对高质量、专业发展培训资源的巨大需求 [4] - 公司最初通过向高等教育机构提供教育内容产品和IT服务开展业务，同时也向个人客户提供产品 [4] - 公司利用其在开发专业发展培训内容方面的强大能力和在整合行业教育内容资源方面的成功经验，建立了全面、多维度的数字教育内容数据库，提供广泛的专业发展产品 [4] - 公司将自有数字教育内容嵌入自主开发的在线学习平台，通过全渠道销售系统向广泛客户提供服务 [4] - 公司还致力于中国教育行业的数字化和信息化 [4]

Millicom (Tigo) intends to consolidate listing of shares on NASDAQ U.S. by delisting SDRs from Nasdaq Stockholm and resumes shareholder remuneration Luxembourg, November 29, 2024 – Millicom International Cellular S.A. ("Millicom" or the “Company”), today announced that the Company’s Board of Directors (the “Board”) has approved the following corporate actions, to simplify the trading of its shares and to resume shareholder remuneration, supported by the Company’s strong financial performance in 2024 and pos ...

MCLEAN, Va., Nov. 27, 2024 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") announced today that, as expected, it received a notice (the "Additional Notice") from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the "Q2 Form 10-Q") and Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Q3 Form 10-Q", and ...

SINGAPORE, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Primech Holdings Limited (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, announced that it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is eligible for an additional 180 calendar day period, or until May 12, 2025, to regain compliance with the Nasdaq's minimum $1 bid price per share requirement. The Company was first notifie ...

Lenexa, KS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on November 25, 2024, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Quarterly Report”). The Nasdaq Listing Rule requires listed companies to timely file all required peri ...

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (“Rule 5250”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended Septem ...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday.The Dow traded down 0.28% to 44,734.33 while the NASDAQ fell 0.66% to 19,048.75. The S&P 500 also fell, dropping, 0.37% to 5,999.25.Check This Out: Jim Cramer: Linde Is A ‘Terrific’ Company, Sees Another Stock Up 75% As ‘Not Done’Leading and Lagging SectorsReal estate shares jumped by 0.9% on Tuesday.In trading on Tuesday, information technology shares fell by 1.4%.Top HeadlineThe US core ...

In Brief Chinese autonomous driving technology company Pony AI will start trading on the Nasdaq on Wednesday at an offering price of $13 per share, the higher end of its expected range.With an initial public offering of 20 million American depositary shares, Pony stands to gain at least $260 million at a $4.55 billion from its debut. The proceeds will likely exceed that. Strategic investors are expected to buy around $153 million worth of Pony AI shares in private placements, and the underwriters — Goldman ...